Correlation Between Sino Biopharmaceutica and Garibaldi Resources

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sino Biopharmaceutica and Garibaldi Resources at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sino Biopharmaceutica and Garibaldi Resources into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sino Biopharmaceutical Limited and Garibaldi Resources Corp, you can compare the effects of market volatilities on Sino Biopharmaceutica and Garibaldi Resources and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sino Biopharmaceutica with a short position of Garibaldi Resources. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sino Biopharmaceutica and Garibaldi Resources.

Diversification Opportunities for Sino Biopharmaceutica and Garibaldi Resources

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between Sino and Garibaldi is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Sino Biopharmaceutical Limited and Garibaldi Resources Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Garibaldi Resources Corp and Sino Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sino Biopharmaceutical Limited are associated (or correlated) with Garibaldi Resources. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Garibaldi Resources Corp has no effect on the direction of Sino Biopharmaceutica i.e., Sino Biopharmaceutica and Garibaldi Resources go up and down completely randomly.

Pair Corralation between Sino Biopharmaceutica and Garibaldi Resources

Assuming the 90 days horizon Sino Biopharmaceutica is expected to generate 31.39 times less return on investment than Garibaldi Resources. But when comparing it to its historical volatility, Sino Biopharmaceutical Limited is 5.48 times less risky than Garibaldi Resources. It trades about 0.01 of its potential returns per unit of risk. Garibaldi Resources Corp is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  17.00  in Garibaldi Resources Corp on September 4, 2024 and sell it today you would lose (12.52) from holding Garibaldi Resources Corp or give up 73.65% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy62.02%
ValuesDaily Returns

Sino Biopharmaceutical Limited  vs.  Garibaldi Resources Corp

 Performance 
       Timeline  
Sino Biopharmaceutical 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sino Biopharmaceutical Limited are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent technical and fundamental indicators, Sino Biopharmaceutica reported solid returns over the last few months and may actually be approaching a breakup point.
Garibaldi Resources Corp 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Garibaldi Resources Corp are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Garibaldi Resources reported solid returns over the last few months and may actually be approaching a breakup point.

Sino Biopharmaceutica and Garibaldi Resources Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sino Biopharmaceutica and Garibaldi Resources

The main advantage of trading using opposite Sino Biopharmaceutica and Garibaldi Resources positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sino Biopharmaceutica position performs unexpectedly, Garibaldi Resources can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Garibaldi Resources will offset losses from the drop in Garibaldi Resources' long position.
The idea behind Sino Biopharmaceutical Limited and Garibaldi Resources Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Bonds Directory
Find actively traded corporate debentures issued by US companies
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.